Chemoradiotherapy with Concurrent Durvalumab for the Palliative Treatment of Oligometastatic Oesophageal and Gastrooesophageal Carcinoma with Dysphagia: A Single Arm Phase II Clinical Trial (PALEO, Sponsored by the Australasian Gastro-Intestinal Trials Group)

Publication
BMC cancer